Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.66 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.66 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.59 |
| ▸ | PI4KA | P42356 | 8/20 | 0.56 |
| ▸ | PI4K2B | Q8TCG2 | 8/20 | 0.56 |
| ▸ | PI4K2A | Q9BTU6 | 8/20 | 0.56 |
| ▸ | PI4KB | Q9UBF8 | 8/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.50 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42314 | 1.00 | ADORA2A (0.66) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL1059581 | 0.81 | NUDT1 (0.68) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL30109321 | 0.81 | NUDT1 (0.68) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL887194 | 0.80 | ADORA2A (0.58) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL8566 | 0.79 | ADORA2A (1.00) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL6831171 | 0.79 | ADORA2A (0.52) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL843169 | 0.79 | ADORA2A (0.61) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL42335 | 0.79 | ADORA2A (0.61) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL842440 | 0.79 | ADORA2A (0.61) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL5490464 | 0.79 | KDM4E (0.44) | ADORA2AADORA1NUDT1PI4KAPI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025081095-A1 | ENGINEERED ACETATE KINASE VARIANTS | CODEXIS, INC. (US) | 2025-04-17 | — | — | WO | claimed |
| CN-122095091-A | DsRNA for inhibiting LPA gene expression and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122095092-A | Inhibitor for inhibiting inhibin Beta E gene expression and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4695420-A1 | CAPTURING AND AMPLIFYING POLYNUCLEOTIDES | Illumina, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4673112-A1 | METHOD OF LYOPHILISATION | GlaxoSmithKline Biologicals S.A. (BE) | 2026-01-07 | — | — | EP | disclosed |
| US-12516314-B2 | Methods for isolating DNA from a blood sample | BIOCAPTIVA LIMITED (GB) | 2026-01-06 | — | — | US | disclosed |
| EP-3696275-B1 | METHOD FOR IMPROVING LOADING AND STABILITY OF NUCLEIC ACID ON SOLID SUPPORT | MGI TECH CO LTD (CN) | 2025-12-24 | — | — | EP | disclosed |
| EP-4658302-A1 | IMMUNOGENIC COMPOSITION | GlaxoSmithKline Biologicals S.A. (BE) | 2025-12-10 | — | — | EP | disclosed |
| EP-4638779-A1 | STERILISED APPARATUS FOR CAPTURING NUCLEIC ACIDS FROM BODY FLUIDS | Biocaptiva Limited (GB) | 2025-10-29 | — | — | EP | disclosed |
| EP-4634200-A1 | ENZYMATIC SYNTHESIS OF NTP AND NQP | Codexis, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| CN-114404581-A | Cancer vaccine | 摩登纳特斯有限公司 | 2022-04-29 | — | — | CN | disclosed |
| EP-3987058-A1 | TYPE III CRISPR/CAS-BASED DIAGNOSTICS | Wageningen Universiteit (NL) | 2022-04-27 | — | — | EP | disclosed |
| EP-3983393-A1 | NOVEL SPIROBICYCLIC INTERMEDIATES | Janssen Pharmaceutica NV (BE) | 2022-04-20 | — | — | EP | disclosed |
| CN-109072298-B | Generation of phased read sets for genome assembly and haplotype phasing | 多弗泰尔基因组学有限责任公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-114207145-A | Type III CRISPR/Cas based diagnostics | 瓦赫宁恩大学 | 2022-03-18 | — | — | CN | disclosed |
| WO-2022056169-A1 | COMPOSITIONS AND METHODS FOR DETECTING AN ABASIC SITE OF A NUCLEIC ACID | ILLUMINA, INC (US) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022055729-A1 | COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES | ILLUMINA, INC. (US) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022051677-A1 | COMPOSITIONS AND METHODS FOR CAPPING RNAS | VERVE THERAPEUTICS, INC. (US) | 2022-03-10 | — | — | WO | disclosed |
| CN-114144422-A | Electrochemiluminescence labeled probes for use in immunization methods, methods of using such probes, and kits comprising such probes | 中尺度技术有限责任公司 | 2022-03-04 | — | — | CN | disclosed |
| EP-3956446-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF NLRP3 INFLAMMASOME MEDIATED IL-1BETA DEPENDENT DISORDERS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-02-23 | — | — | EP | disclosed |